NCT01008046View on ClinicalTrials.gov

N-acetyl Cysteine and Clomiphene Citrate or Metformin and Clomiphene Citrate for Women With CC Resistant Polycystic Ovary Syndrome (PCOS).

NACompletedINTERVENTIONAL
Enrollment

192

Participants

Timeline

Start Date

April 30, 2007

Primary Completion Date

June 30, 2009

Study Completion Date

June 30, 2009

Conditions
Polycystic Ovary Syndrome
Interventions
DRUG

combined N-acetyl cysteine -CC

N-acetyl cysteine(1.8 g orally daily)for 5-6 weeks from the 1st day of spontaneous or induced menstruation followed by 100 mg CC for 5 days from day 3 of spontaneous or induced menstruation. With persistent anovulation,CC increased by 50 mg for the next cycle. Treatment continued for three successive cycles

DRUG

combined metformin-CC

Patients received metformin HCl (1500 mg daily) for 5-6 weeks from the 1st day of spontaneous or induced menstruation, followed by 100 mg CC for 5 days starting from day 3 of spontaneous or induced menstruation. With persistent anovulation,CC increased by 50 mg for the next cycle. Treatment continued for three successive cycles

Trial Locations (1)

Unknown

Mansoura University Hospitals,OB/GYN department, Al Mansurah

All Listed Sponsors
lead

Mansoura University

OTHER

NCT01008046 - N-acetyl Cysteine and Clomiphene Citrate or Metformin and Clomiphene Citrate for Women With CC Resistant Polycystic Ovary Syndrome (PCOS). | Biotech Hunter | Biotech Hunter